Predictive value of 18 F-FDG PET/CT and serum tumor markers for tumor mutational burden in patients with non-small cell lung cancer.

PURPOSE:To investigate the correlations between metabolic parameters (MPs) of 18MATERIALS AND METHODS:In this retrospective study, we enrolled 129 patients with NSCLC (males, 78; females, 51) who underwent baseline TMB and STM tests and 18RESULTS:For ADC, all MPs (SUL peakmaxmeanpeakCONCLUSION:MPs and STMs can predict the TMB level for patients with ADC, and may serve as potential substitutes for TMB with increased value and easy implementation in guiding immunotherapy through noninvasive methods.